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Porcine circovirus 2 (PCV2) is a single stranded DNA virus with one of the highest mutation rates 
among DNA viruses. This ability allows it to generate a cloud of mutants constantly providing new 
opportunities to adapt and evade the immune system. This pig pathogen is associated to many 
diseases, globally called porcine circovirus diseases (PCVD) and has been a threat to pig industry since 
its discovery in the early 90’s. Although 11 ORFs have been predicted from its genome, only two main 
proteins have been deeply characterized, i.e. Rep and Cap. The structural Cap protein possesses the 
majority of the epitopic determinants of this non‑enveloped virus. The evolution of PCV2 is affected 
by both natural and vaccine‑induced immune responses, which enhances the genetic variability, 
especially in the most immunogenic Cap region. Intra‑host variability has been also demonstrated in 
infected animals where long‑lasting infections can take place. However, the association between this 
intra‑host variability and pathogenesis has never been studied for this virus. Here, the within‑host 
PCV2 variability was monitored over time by next generation sequencing during an experimental 
infection, demonstrating the presence of large heterogeneity. Remarkably, the level of quasispecies 
diversity, affecting particularly the Cap coding region, was statistically different depending on viremia 
levels and clinical signs detected after infection. Moreover, we proved the existence of hyper mutant 
subjects harboring a remarkably higher number of genetic variants. Altogether, these results suggest 
an interaction between genetic diversity, host immune system and disease severity.
The viral life-cycle is essentially dominated by a complex balance of interaction and competition with the host. 
To elude host defenses, different viral families have developed several strategies. These strategies can be broadly 
categorized into two non-mutually exclusive classes: (i) the ability to down-regulate the host immune responses, 
and (ii) the ability to evade the mounted immunity. While large complex viruses possess a broad set of proteins 
to interact with the host immune pathways, relatively simple RNA and single strand DNA (ssDNA) viruses, rely 
mainly on the genesis of new variants able to escape the immunity of the host and thereafter, potentially, of a 
broader population. In fact, the estimated evolutionary rate of these viruses is in the range of  10–3–10–6 substi-
tution/site/year, corresponding to an average of one mutation per replication  cycle1–5. The continuous genesis 
of a plethora of new mutants provides a huge substrate in which natural selection can act, favoring those more 
adapted to the new environment. Porcine circovirus type 2 (PCV2) belongs to this viral group, displaying one 
of the higher evolutionary rate among DNA viruses (~ 10–3)6,7, in the range of RNA viruses. Initially described 
in systemically diseased animals in 1991 in  Canada8, PCV2 infection has been thereafter reported worldwide 
in association to several clinical conditions, including PCV2-systemic disease (PCV2-SD), PCV2-reproductive 
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disease and porcine dermatitis and nephropathy syndrome, which are globally overall called Porcine circovirus 
diseases (PCVD)9. PCV2 is featured by a circular ssDNA genome of about 1.7 kb coding for a limited protein 
number. Although at least 11 ORF have been putatively identified, only 6 of them have been characterized to 
code biologically relevant  proteins10. Particularly, only ORF1 and ORF2 are essential for PCV2 replication. ORF1 
encode, through alternative splicing, two proteins (Rep and Rep’) involved in the rolling circle replication process. 
ORF2 protein, on the other hand, is the only PCV2 structural protein constituting the icosahedral viral capsid. 
Therefore, it plays a pivotal biological role being involved in viral attachment but also containing the majority 
of epitopic determinants.
The other ORFs (ORFs 3 to 6) coding for non-structural proteins not essential for viral replication, are 
involved in regulating cell apoptosis and interacting with the transcription and function of other viral/host pro-
teins, potentially enhancing viral replication, survival, and even immune  evasion11–14. A significant action of the 
host immune response, both natural and vaccine-induced7,15, has been demonstrated to affect PCV2 evolution, 
likely contributing to enhance the high genetic variability of this worldwide distributed virus. A noteworthy 
intra-host variability has been demonstrated in PCV2 infected  subjects16, which could be of great relevance 
by constituting a substratum for larger scale evolution (i.e. population level). Additionally, a role on PCVD 
pathogenesis could also be hypothesized. In fact, PCV2 is able to establish relatively long-lasting infections, 
persisting for weeks or months. Hence, some mechanisms of immune evasion can be expected, as suggested by 
the higher within-host heterogeneity in the more immunogenic Cap coding gene (ORF 2) compared to other 
genomic  regions16. Additionally, PCV2 interaction with the host immune system is particularly complex, since 
both immune activation and suppression have been proven to enhance viral replication, correlating with the 
emergence of overt clinical  signs17,18. While an association between intra-host variability and pathogenesis or 
disease progression has been demonstrated for several human and animal  infections19–22, such issue has never 
been investigated for PCV2.
Therefore, in the present study, the within-host PCV2 variability was monitored over time by next genera-
tion sequencing (NGS) in experimentally infected animals showing different clinical outcomes and viral loads.
Results
Pathological and virological characteristics of studied animals. An experimental inoculation 
of 6-weeks-old healthy pigs with very low PCV2 antibody titers (≤ 1:80), was done with PCV2b as inoculum. 
Serum samples from 23 pigs were used for high throughput sequencing. These animals were selected based 
on two main variables: PCV2 viremia measured by real-time quantitative  PCR23 and fulfillment or not of the 
diagnostic criteria for PCV2-SD9. Viremia was considered high when ≥ 7  log10 PCV2 genome copies/mL were 
detected in serum at 3 weeks post-inoculation (wpi), and low when this was < 7  log10 PCV2 genome copies/mL in 
serum. PCV2-SD was diagnosed when animals displayed weight loss and fulfilled the histopathological criteria 
of moderate to severe lymphocyte depletion (LD) and granulomatous inflammation (GI) of lymphoid tissues, 
and harbored moderate to high amount of PCV2 nucleic acid measured by in situ hybridization (ISH) in these 
tissues (mean pathological combined score > 1.5). Animals that did not accomplish the abovementioned defini-
tion were considered as non-PCV2-SD (mean pathological combined score < 1.5).
These 23 animals were divided in the following three groups: Group 1 (PCV2-SD, n = 8); Group 2 (low 
viremia, non-PCV2-SD, n = 8); and Group 3 (high viremia, non-PCV2-SD, n = 7). A summary of the main 
characteristics of the different groups of pigs selected for metagenomic analyses (n = 23) is indicated in Table 1.
Viral and antibody titers. Animals displayed detectable viral loads in serum, as well as in nasal and rectal 
swabs during the study period (Fig. 1). Particularly, PCV2 DNA could be detected from 1 wpi in serum and nasal 
swabs (NS), and from 2 wpi in rectal swabs (RS).
Seroconversion was evident from 2 wpi onwards in all studied animals and featured by a significant (P < 0.05) 
increase in antibody titers (Fig. 1a). A significant (P < 0.05) increase viral titer was observable in all groups at 
1 wpi in serum and at 2 wpi in NS and RS. No significant differences were observed among groups except for 
PCV2 titer in serum between group 2 and 3, at 3 wpi.
Viral subpopulation variation. The reconstructed viral consensus sequences (based on a majority con-
sensus rule) showed identity with the inoculum sequence, irrespectively of the pig sampled, clinical group and 
collection time. However, the evaluation of single nucleotide variations (SNV) throughout the whole genome 
in different groups demonstrated a quite different trend. Despite the within-host viral heterogenicity was simi-
lar at 1 wpi, the group with high viral load in serum but no overt clinical signs (Group 3) showed a progres-
Table 1.  Main characteristics of selected pigs for genetic analyses. The characteristics that were used as 
selection criteria of inclusion are bolded.
Characteristics Group 1 (n = 8) Group 2 (n = 8) Group 3 (n = 7)
PCV2-SD diagnosis Yes No No
PCV2 load (log genome copies/mL) at 3 wpi 4.94–7.83 4.64–6.72 7.01–9.54
Histopathological score range 1.5–3 0.25–1.08 0.17–1.08
Average daily weight gain 230 ± 83 g/day 480 ± 136 g/day 470 ± 81 g/day
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sive increase in SNV frequency along the genome over time, with several variable positions shared by different 
subjects (Fig. 2). On the contrary, an extremely low pathogen genetic variability was detected in diseased pigs 
(Group 1) over the whole study period, while animals from Group 2 evidenced an intermediate pattern. The 
results were confirmed by overall entropy evaluation and comparison (Fig. 3a). Since entropy is associated with 
the amount of disorder in a system, it can represent an effective summary statistic of the overall variability of 
viral quasispecies within the ‘host system’. A significant difference (P < 0.05) between groups at all considered 
time points was evidenced through Kruskal–Wallis test when analyzing the full genome with, a highly significant 
difference detected only at 3 wpi (P < 0.001). Based on pairwise Mann‐Whitney tests, Group 1 showed a higher 
entropy compared to Group 2 at 1 wpi (P = 0.014), while group 3 had a higher diversity compared to Group 1 
(P = 0.044) at 2 wpi. At 3 wpi, animals from Group 3 displayed a higher entropy compared to Group 2 (P = 0.034) 
and 1 (P < 0.001), while a significantly higher entropy was observed in Group 2 compared to Group 1 (P = 0.007). 
The animal #180 from Group 3 showed the same mutations at different wpi, while most of the SNVs were 
detected at only one sampling point for the other animals (Supplementary Fig. 1). 
The analysis to estimate the variations in entropy over time were also done for ORF1 and ORF2, indepen-
dently. The Cap coding region (ORF2) showed the higher average entropy for all groups following the same 
trends over time (Fig. 3). Kruskal–Wallis test evidenced a significant difference between groups at both 1 wpi 
(P = 0.014) and 3 wpi (P < 0.001). Specifically, a significant difference was found at 1 wpi between Groups 1 and 
2 (P = 0.025), and at 3 wpi between Groups 2 and 3 (P = 0.026) and Groups 1 and 3 (P < 0.001). Although the Rep 
coding region demonstrated an overall lower entropy, the between-group difference became even more evident 
compared to other regions. Kruskal–Wallis test evidenced a significant difference at 2 and 3 wpi (P < 0.001). 
Group 3 was statistically different form Group 2 (P = 0.002) and Group 1 (P < 0.001) at 2 wpi. At 3 wpi, Group 1 
was significantly different from Group 2 (P = 0.001) and Group 3 (P < 0.001).
The relationship between antibody titers and entropy was also explored. Despite a certain correlation tendency 
was observed (Supplementary Fig. 2), the association was not statistically significant.
Individual level entropy. A pig by pig entropy analysis was also performed to explore the within-host 
viral heterogeneity. A remarkable heterogeneity among animals was observed, especially in animal 153 (from 
Group 2) which showed a relevant entropy increase at week 3, and animal 180 (from Group 3) which showed 
this increased variability in viral subpopulations compared to the other subjects starting from 2 wpi. (Fig. 4). A 
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Figure 1.  The average and 95% confidence intervals of  log2 antibody titers (IPMA) measured in sera (a) and 
 log10 PCV2 copies in 1 ml of PBS in nasal (b) and rectal swab (c) suspensions and 1 ml of serum (d) are reported 
for each wpi. Different groups have been color-coded. 
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more detailed analysis revealed that the difference was mainly focused on the Rep coding region of these sub-
jects (Supplementary Fig. 3). In fact, when these subjects were excluded, the entropy difference among groups 
remained true for the Cap region, while the difference became less evident in the Rep gene region, although the 
Group 3 still demonstrated the higher variability at 3 wpi (Fig. 3b).
Discussion
The presence of a large within-host viral heterogeneity, often referred as quasispecies, has been demonstrated for 
several viruses. The continuous generation of new variants can play a relevant role in viral biology, persistence 
and pathogenesis, allowing viruses to either modify their cell and host tropism or to overcome inhibiting factors 
like host immune response or antiviral  therapies24,25.
Currently, the vast majority of available knowledge has been obtained from a limited number of chronic/
life-lasting infectious diseases caused by RNA viruses, like the Human Immunodeficiency Virus, Hepatitis C 
Virus, Hepatitis B  Virus26. A lower amount of data obtained from acute infections (still essentially caused by 
rapidly evolving RNA viruses) has demonstrated the existence of a noteworthy intra-host variability and sug-
gested its effect on viral evolution and disease  features19,22,27. However, the relationship between the mutant 
spectrum and the clinical outcome is often unclear, poorly understood and hardly generalizable. In fact, both 
positive and negative correlation between quasispecies diversity and disease severity have been described with 
contradictory  results19,22.
Features of viral quasispecies from single-stranded circular DNA viruses like PCVs have been less investi-
gated, especially for animal viruses. Their evolutionary potential should be of higher interest to human health 
and farm profitability, since the intensive farming determine favorable conditions for the generation of huge and 
interconnected viral mutant clouds, which allows for a rapid exploration of the fitness landscape and leads to a 
remarkable adaptive potential to new environments. Significantly, global pork production has increased by more 
than 80% between 1985 and 2010, which went with a modification in the productive system and the emergence 
and discovery of tens of pathogens and pathogens  variants28. A recent study has investigated the presence, features 
and epidemiological relevance of PCV2 quasispecies in field  conditions16. Still, the linkage between intra-host 
heterogeneity and PCVD has never been investigated.
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Figure 2.  The SNV frequency is reported for each genome position. The regions corresponding to the ORF1 
and ORF2 have been represented as red and black lines, respectively. Error bars indicate the presence of multiple 
subjects harboring the same SNV and describe the frequency variability. The wpi are reported as columns while 
the different groups are reported in separate rows.
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The present study, performed in more controlled experimental settings, allowed to highlight two main results: 
(1) the presence of a significant difference in quasispecies extent depending on viremia level and clinical signs 
emergence; (2) the existence of ‘hypermutant’ subjects, harboring a remarkably higher number of viral genetic 
variants. Animals with no clinical signs demonstrated an increased within-host viral heterogeneity, which was 
particularly evident in highly viremic subjects. On the contrary, the viral genetic variability of pigs developing 
overt clinical signs, clearly decreased from 2 wpi until the end of the study, although it was comparable to the 
other groups at the beginning (1 wpi). These data suggest a likely interaction between viral population diversity 
and disease severity, as reported for other  pathogens19,22,29.
The Cap gene region was characterized by a higher entropy, posing in favor of a pivotal role of the host 
immune response in shaping viral  heterogeneity7,15,16. PCV2 pathogenesis is deeply bound to the host immune 
system. In fact, while an effective immune response can control PCV2 infection, the virus relies on actively 
replicating cell for its own replication. The direct consequences of viral replication, especially in immune cells, 
and the deregulation of immune signaling can cause a severe immunosuppression in infected animals. Actually, 
PCV2-SD is characterized by a significant lymphocyte depletion in lymphoid tissues and alteration of cytokine 
and chemokine expression  profile17,18. Based on these premises, two components are likely to contribute to the 
observed scenario: the viremia level (i.e. the effective population size) and the immune system effectiveness (i.e. 
the selective pressure). Because of the high mutation rate, a more pronounced replication could easily justify 
the marked viral heterogeneity observed only in highly viremic animals. However, the totally different entropy 
pattern observed in clinical (Group 1) and sub-clinical animals (Groups 2 and 3) suggests that other forces must 
be in action. We hypothesize that the virus-induced immunosuppression in diseased animals may lead to a 
lower selection coefficient. The absence of significant differences in Ab titers among clinically and subclinically 
affected pigs appears to contrast this hypothesis. Nonetheless, it must be kept in mind that IPMA are a quite 
generic measure of host response (total antibodies), and future studies of immune cell population composition 
and activation should be performed to give light on this hypothesis. Although it is known that IPMA antibod-
ies correlate positively with neutralizing antibodies (NA), pigs with higher viral loads tend to have lower titers 
of  NA30. Therefore, it cannot be ruled out that differences in NA titers would have been detected if measured.
A potential alternative hypothesis is the emergence and predominance of a limited number of (or single) more 
virulent variants, which was responsible for the overt disease in just a subset of animals. However, no variations 
were observed at consensus sequence level, proving that none of these mutations effectively reached fixation. 
Similarly, few SNV appeared to persist over time independently of the considered group. Significant perturbations 
Complete genome Cap Rep
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Figure 3.  The entropy average and 95% confidence intervals of the complete genome and Cap and Rep coding 
regions are reported for each wpi. The different groups have been color-coded. The entropy values are reported 
for the complete dataset (a) and after excluding the ‘hypermutant’ subjects (i.e. 153 and 180) (b). Asterisks 
indicate the presence of significant differences among groups.
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occurring in a mutant-spectra without any modification in the consensus sequence have already been reported, 
and evolution can therefore be viewed in terms of a disequilibrium and variations of these  spectrum24. In fact, 
a viral quasispecies represents a single selection unit where variants are not selected based on their individual 
fitness, but on the fitness of the overall mutant distribution whose components share the selectable  trait31,32. The 
PCV2 scenario herein observed appears to conform to this principle. Pigs with an effective immune system able 
to avoid disease emergence, are apparently selecting for a broad quasispecies rather than individual escaping 
variant. When a mutant spectrum harbors a wide repository of variants, selection of genome subsets in a new 
environment can be very rapid, which could be more beneficial for long-term viral persistence within host, 
compared to single escape-mutant selection. While the reproductive advantage of the latter could be promptly 
limited by new antibody or cell response development or due to cross-reactivity in other antigenic sites, a larger 
quasispecies cloud further enhance the sequence space exploration potential, and thus the likelihood of transi-
tory emergence of at least partially immune escape variants.
The above-mentioned pattern, although less evident, holds true also excluding from the analysis the ‘hyper-
mutant’ individuals: subclinical-high viremic groups demonstrated a more pronounced variability compared 
to PCV2-SD affected ones at least at 3 wpi (Fig. 3b). The most notable difference is represented by the Rep gene, 
where after ‘hypermutant’ subjects exclusion, the differences among groups becomes essentially negligible with a 
much lower entropy compared to the Cap gene. The causes behind the higher variability observed within certain 
subjects remains obscure. Even if a higher sequencing error frequency could be hypothesized, the samples were 
processed using the same methods and sequenced in the same Ion Torrent run, making this scenario unlikely. 
Previous studies performed on human pathogens have evidenced the occurrence of remarkable differences in 
within-host variability between  individuals22,33. Additionally, fluctuations in the genetic composition were proven 
to occur in viral population replicating in stable environments, suggesting that this disequilibria may provide a 
selective advantage to viruses that can be then fully exploited in changing  environments34, like the ones induced 
by the host immune system or by replication in different cell or tissues. Interestingly, a higher than expected 
variability was observed in the ORF1 region in both ‘hypermutants’ pigs, potentially leading to alterations in viral 
replicative capabilities. Although an obvious impact on viral virulence was not observed, being ‘hyper mutants’ 
pigs asymptomatic animals, the epidemiological role of these subjects must be carefully considered since they 
could represent an incubator and amplifier of new variants, which might be then transmitted and selected at 
population level. The present study confirms the quasispecies nature of PCV2 infection, which appears to be 
affected mainly by a combination of viral population size and immune selection pressure efficacy. Pigs with 
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Figure 4.  The entropy average and 95% confidence intervals of the complete genome are reported for each 
subject and wpi. Different groups have been color-coded.
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overt clinical signs, involving immunosuppression, seem to induce much lower selective pressure than healthy 
animals, leading to quite homogeneous viral populations. Immune pressure may probably act on the whole 
mutant spectrum breadth and thus on the viral evolution potential and plasticity, rather than on specific muta-
tions or variants. The detection of ‘hypermutant’ subjects will require further investigations on the causes and 
frequency of this phenomenon, since the epidemiological relevance cannot be underestimated. The obtained data 
stresses once more the need for controlling PCV2 population size both at individual and population level, which 
requires the effective implementation of biosecurity measures and the application (and potentially improvement) 
of vaccination protocols able to constrain the within host replication potential and the consequent risk of new 
variants emergence.
Methods
Experiment design and sample collection. Twenty-three 6 weeks-old nursery pigs from a larger exper-
imental study (unpublished data) were included in the analyses. Prior to inoculation, animals had healthy con-
dition and very low PCV2 antibody titers (≤ 1:80) measured by immunoperoxidase monolayer assay (IPMA)35, 
which were equivalent to ELISA negative  values36. In addition, pigs were negative to PCV2 by real-time quantita-
tive PCR (qPCR)23. After 1 week of acclimation, all pigs were inoculated intranasally (2 mL, half of the volume 
was administered in each nostril) and intramuscularly (1 mL on the left neck muscles) with  104,5  TCID50/animal 
of a PCV2b isolate (inoculum). Animals were longitudinally monitored for three weeks, with a daily clinical 
observation. Serum samples, and both nasal and rectal swabs were collected on a weekly basis. Animals were 
weighted at the inoculation day and subsequently at the necropsy day; average daily weight gain (ADWG) was 
calculated. All animals were euthanized at three weeks post-inoculation (wpi) with an overdose of barbiturate.
Animal care and study procedures were conducted under the approval of the Ethical and Animal Welfare 
Committee of the Universitat Autonoma of Barcelona and the Animal Experimentation Commission from the 
local government (Dpt. de Medi Ambient i Habitatge from the Generalitat de Catalunya; Reference 5796). All 
experiments were performed in accordance with relevant guidelines and regulations.
Pathological studies. A complete examination of each animal was performed at necropsy and samples 
of tonsil, spleen, inguinal superficial lymph node and mesenteric lymph node were collected and fixed by 
immersion in 10% buffered formalin. These lymphoid tissues were scored for LD and GI following a previously 
described scoring  system37. In addition, detection of PCV2 genome by ISH was also performed on the same 
tissues and scored for the amount of viral DNA (absence, low, moderate or high; 0 to 3 respectively) based on 
Rosell et al. (1999)37. A combined mean pathological score (from 0 to 3) including LD, GI and ISH scores was 
generated per tissue and per animal. Values from 0 to 1.5 were considered compatible with a PCV2 subclinical 
infection (PCV2-SI) and, therefore, were classified as non-PCV2-SD, while values ≥ 1.5 were considered compat-
ible with PCV2-SD.
Quantitative PCR and serology. DNA extraction/qPCR. DNA was extracted from 200 µL of serum or 
300 µL of nasal swab suspensions following the Nucleospin Blood (Macherey–Nagel, GmbH & Co KG, Düren, 
Germany) manufacturer’s instructions. DNA from rectal swab was extracted from 300 µl of swab suspensions 
according to the QIAamp DNA Stool Mini Kit (Qiagen GmbH, Germany) recommendations. PCV2 was ampli-
fied and quantified using as described by Olvera et al. (2004)23. PCV2 load is expressed as  log10 PCV2 DNA cop-
ies per mL of serum or PBS (swab suspension). The sensitivity of this technique is between 3–4  log10 copies/mL.
PCV2 antibody detection. Antibody titers against PCV2 were measured by IPMA following previously 
described  protocols38. IPMA results were expressed in  Log2 titers.
DNA extraction and high throughput sequencing. DNA from sera samples from selected animals 
together with the inoculum were extracted using MiniElute Virus kit (QIAGEN) and full PCV2 genome ampli-
fication was done following the protocol described  before39. Briefly, the optimized 50 µl PCR contained 15 pmol 
of each primer (PCV490F, 5′-TCC GCG GGC TGG CTG AAC TTT TGA -3′ and PCV497R 5′-CCC GCG GAA ATT 
TCT GAC AAA CGT -3′), 0.3 mM dNTPs, 3 µl extracted DNA and 5 U Superfi high-fidelity DNA polymerase 
(Invitrogen). The amplicons were purified by the QIAquick PCR purification kit (QIAGEN), eluted in 30  µl 
Tris buffer and quantified and quality assessed by the Agilent High Sensitivity DNA kit (Agilent Technologies). 
All DNA samples were individually deep-sequenced using Ion-Torrent platform and analyzed to evaluate the 
within-subject PCV2 variability over time and its association with different clinical outcomes.
Bioinformatics analysis. Read quality of obtained FASTQ files was visually inspected using  PRINTSEQ40. 
Reads that were shorter than 30 bp in length, with an average quality lower than 20 or had more than one base 
with a quality lower than 10, were filtered out. Additionally, tag removal and trimming of poor-quality bases, 
poly-N at 5′ and 3′ tails was performed using the same software. Reads were aligned to the PCV2 reference 
genome (NC_005148) using  Bowtie241. Samtools was used to convert and sort the obtained SAM  files42. Finally, 
sample specific coverage and consensus sequence were obtained using  QUASR43.
Subpopulation study. The discrimination between true mutation and sequencing errors represent one of 
the main challenge of NGS-based technologies. To evaluate the presence of viral subpopulations, each position-
specific single nucleotide variations (SNV) and its frequency was identified with the highly specific LoFreq 
 method44, implementing a Poisson–binomial distribution model and accounting for base-call quality value as 
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well as other sources of uncertainty to identify true variants from sequencing errors. The significance level was 
set to a P value < 0.01.
Statistical analyses. To compare the within sample variability, Shannon-entropy was calculated for each 
genome position in each PCV2 sample (i.e. for each selected animal and sampling time) using QuRe imple-
menting a Poisson-binomial distribution model for NGS-error  correction45. The overall entropy was assumed 
as summary statistic representative of the overall within-host viral heterogeneity. The presence of a statistical 
difference in entropy level among the defined groups and/or week post-infection was evaluated using the non-
parametric Kruskal–Wallis test, followed by post-hoc tests (Mann–Whitney tests) with Bonferroni correction. 
A similar approach was used to evaluate the presence of statistical difference in viral loads and antibody titers 
among defined groups over at different time points. The relationship between viral load and antibodies titers and 
average entropy was also assessed calculating the Spearman correlation coefficient, for each sampling time and 
on the whole study duration. The statistical significance level was set to p < 0.05.
Data availability
The entire sequence dataset is available in the Sequence Read Archive (SRA) database with submission number 
SUB6925781. The consensus sequence used is available at Genbank with accession number MT951192.
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